YM087

· Cumberland Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YM087, covering 2014-05-02 to 2014-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia [Phase 3]